Lupin launches Softovac Liquifibre, a first-of-its-kind liquid fibre

LupinLife, the consumer healthcare business of global pharma major, Lupin Limited (Lupin) announced the launch of Softovac Liquifibre, a 100% ayurvedic liquid laxative. With this, the company enters the Indian liquid laxative market with this innovative product that is a formulation of Isabgol fibre in liquid form and natural actives such as Sonamukhi, Harad, Mulethi, Saunf, Amaltas and Gulab Dal.

Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested ayurvedic ingredients. The product has been proven safe and clinically efficacious versus benchmark liquid laxative products.

Rajeev Sibal, president – India Region Formulations, Lupin said, “Studies indicate that constipation impacts the daily lives and productivity of millions. Softovac has been the go-to product for this condition for many years now. The new Softovac Liquifibre is an ayurvedic solution that is clinically validated for efficacy and safety. We have leveraged advanced technologies to achieve optimal particle size of the key ingredient, Isabgol, in this liquid formula, enhancing its palatability. Softovac Liquifibre is a gentle and non-habit forming formula, ensuring efficacy along with comfort and well-being for its users.”

With its appealing mango-flavoured, sugar-free formulation, Softovac Liquifibre is also suitable for diabetics and is available in 225 ml bottles at all leading chemists and pharmacies in India.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!